Molecular pathogen detection - miami VAMC

Ended Awarded Last action

Contract number
36C24823N0079
Awardee
Awarding agency
Obligated
$556,524

Award facts

Contract value 100% obligated
$556,524.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Emigration Canyon, UT 84108, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · MOD to DE-obligate FY23 funds. Molecular pathogen detection -$113,055
Original award $669,579

About this award

This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services at the Miami VA Medical Center (VAMC). The contract, valued at $556,524, was awarded on October 1, 2022 and has a completion date of September 30, 2023. The contract is a Blanket Purchase Agreement (BPA) Call placed against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. No set-aside designation was used. Biofire Diagnostics LLC has previously received numerous federal contract awards to provide a range of infectious disease testing products and services to agencies such as the Department of Veterans Affairs (VA) Veterans Health Administration (VHA), the Defense Health Agency, the Department of Health and Human Services Indian Health Service, and the Department of State. The company also serves as a subcontractor for COVID-19 testing reproducibility studies.

Quick answers

Who was awarded contract 36C24823N0079?

36C24823N0079 was awarded to Biofire Diagnostics LLC by Veterans Integrated Service Network 8 (Veterans Health Administration) on October 1, 2022.

How much is contract 36C24823N0079 worth?

The government has obligated $556,524 on 36C24823N0079.

Is contract 36C24823N0079 an order under another contract?

Yes. 36C24823N0079 is a BPA call under V797D30085-36C24820A0028, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C24823N0079 competed?

The extent of competition for 36C24823N0079 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award